Are you Dr. Seshadri?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-520-5000Fax+1 206-520-5620
Summary
- Dr. Chetan Seshadri, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Massachusetts, and North Carolina. He is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2005 - 2008
Duke University HospitalResidency, Internal Medicine, 2001 - 2004
Rutgers New Jersey Medical SchoolClass of 2001
Certifications & Licensure
WA State Medical License 2009 - 2026
MA State Medical License 2004 - 2010
NC State Medical License 2001 - 2004
Publications & Presentations
PubMed
- 182 citationsImmunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D. Simmons, Catherine M. Stein, Chetan Seshadri, Monica Campo, Galit Alter
Nature Reviews. Immunology. 2018-09-01 - 154 citationsIFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.Lenette L. Lu, Malisa T. Smith, Krystle K. Q. Yu, Corinne Luedemann, Todd J. Suscovich
Nature Medicine. 2019-05-20 - 101 citationsCD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humansAnne Kasmar, Ildiko Van Rhijn, Tan Yun Cheng, Marie T Turner, Chetan Seshadri
The Journal of Experimental Medicine. 2011-08-29
Press Mentions
UW Medicine to Get up to $5.3M for TB Research CenterApril 6th, 2022- ‘Large’ TB Outbreak Could Affect 800 Incarcerated People in Washington StateDecember 16th, 2023
